BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/19/2017 11:33:53 AM | Browse: 842 | Download: 1206
Publication Name World Journal of Gastroenterology
Manuscript ID 34820
Country/Territory Japan
Received
2017-05-27 01:00
Peer-Review Started
2017-05-28 14:15
To Make the First Decision
2017-06-22 00:59
Return for Revision
2017-06-23 09:22
Revised
2017-07-04 14:22
Second Decision
2017-07-21 08:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-07-24 02:32
Articles in Press
2017-07-24 02:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2017-08-11 12:08
Publish the Manuscript Online
2017-08-19 11:33
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
Manuscript Source Invited Manuscript
All Author List Tatsuo Kanda and Mitsuhiko Moriyama
ORCID
Author(s) ORCID Number
Tatsuo Kanda http://orcid.org/0000-0002-9565-4669
Mitsuhiko Moriyama http://orcid.org/0000-0002-4617-508X
Funding Agency and Grant Number
Corresponding Author Tatsuo Kanda, MD, PhD, Associate Professor, Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. kandat-cib@umin.ac.jp
Key Words Cholesterol; Hepatitis C virus; Interferon-free; Lipid metabolism
Core Tip Eradication of hepatitis C virus (HCV) de­creases the rate of complications, including liver-related and liver-unrelated death, and improves patient quality of life. Individuals infected with HCV have an increased risk of cardiovascular diseases and intracerebral hemorrhage, which are both associated with lipid metabolism. HCV infection causes abnormal host lipid metabolism. Treatment with interferon-based and interferon-free regimens has an impact on the eradication of HCV, as well as lipid abnormalities, during treatment and after treatment. Further observations are needed to determine the long-term effects on lipid metabolism caused by HCV and by eradication of the virus.
Publish Date 2017-08-19 11:33
Citation Kanda T, Moriyama M. Direct-acting antiviral agents against hepatitis C virus and lipid metabolism. World J Gastroenterol 2017; 23(31): 5645-5649
URL http://www.wjgnet.com/1007-9327/full/v23/i31/5645.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i31.5645
Full Article (PDF) WJG-23-5645.pdf
Full Article (Word) WJG-23-5645.doc
Manuscript File 34820-Review.docx
Answering Reviewers 34820-Answering reviewers.pdf
Audio Core Tip 34820-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 34820-Conflict-of-interest statement.pdf
Copyright License Agreement 34820-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 34820-Language certificate.pdf
Peer-review Report 34820-Peer-review(s).pdf
Scientific Misconduct Check 34820-Scientific misconduct check.pdf
Scientific Editor Work List 34820-Scientific editor work list.pdf